Search results
3 Magnificent Technology ETFs to Buy With $10,000 and Hold Forever
Motley Fool via Yahoo Finance· 3 hours agolong January 2025 $290 calls on Accenture Plc, long January 2025 $45 calls on Intel, long January...
Should You Buy ChargePoint While More Money Is Going Out Than Coming In?
Motley Fool via Yahoo Finance· 2 hours agoBut there's one problem for investors: The company isn't profitable. Is now the time to buy...
Houston area’s flood problems offer lessons for cities trying to adapt to a changing climate
The Conversation via Yahoo News· 2 hours agoIn most cases, local officials’ initial instinct has been to protect property and persist without...
Britain would be better off with fewer buy-to-let landlords, says L&G
The Telegraph via Yahoo Finance· 3 hours agoHe is spearheading L&G’s push into the build-to-rent industry...that renters should expect. That’s...
8 Purchases Boomers Should Never Make During Retirement
GOBankingRates via Yahoo Finance· 3 hours agoOnce they retire, many seniors change their spending patterns quite a bit. There's nothing...
1 Wall Street Analyst Thinks Alphabet Stock Is Going to $200. Is It a Buy?
Motley Fool via Yahoo Finance· 2 hours agoSo I think Alphabet's best days as a stock may still be ahead of it, and it's a safe bet that the...
Warren Buffett Bought $9.2 Billion of This Stock Last Year, and He Could Buy Even More in 2024
Motley Fool via Yahoo Finance· 3 hours agoIn mid-2018, the board agreed to allow Buffett to buy shares of Berkshire Hathaway as long as both...
5 Electric Car Prices That Tesla Can’t Beat
GOBankingRates via Yahoo Finance· 2 hours agoWhen it comes to electric vehicles, there is one name that rules the game: Tesla. There is a reputation that comes with being one of the pioneers of the...
3 Artificial Intelligence (AI) Stocks to Buy With $715 and Hold for Decades
Motley Fool via Yahoo Finance· 5 hours agoGiven its massive market share, Arm will undoubtedly grow on these tailwinds. That makes this stock...
3 Reasons to Buy AbbVie Stock on the Dip
Motley Fool via Yahoo Finance· 3 hours agoThe dividend remains attractive AbbVie's excellent dividend program remains one of the best reasons to buy the stock. Humira's patent cliff did nothing...
